Frequency of biologic switching and the outcomes of switching in children and young people with juvenile idiopathic arthritis: a national cohort study

BACKGROUND: Information is scarce about biological disease-modifying antirheumatic drug (DMARD) switching patterns in children and young people (aged ≤16 years) with juvenile idiopathic arthritis in an era of many biologic therapies. The best choice of biologic to use if the first biological DMARD i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kearsley-Fleet, Lianne, Heaf, Eleanor, Davies, Rebecca, Baildam, Eileen, Beresford, Michael W, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy, Hyrich, Kimme L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134528/
https://www.ncbi.nlm.nih.gov/pubmed/32280951
http://dx.doi.org/10.1016/S2665-9913(20)30025-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134528/
https://www.ncbi.nlm.nih.gov/pubmed/32280951
http://dx.doi.org/10.1016/S2665-9913(20)30025-4

Ejemplares similares